October 6, 2026
Breaking
Business

AstraZeneca CEO says Summit drug could drive next generation of cancer combinations after $2 billion investment

admin1 min read

Pascal Soriot spoke exclusively with CNBC from the site of AstraZeneca’s new $1 billion R&D facility in Kendall Square in Cambridge, Massachusetts.

The post AstraZeneca CEO says Summit drug could drive next generation of cancer combinations after $2 billion investment appeared first on Business News.

Leave a Comment

Your email address will not be published. Required fields are marked *